Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract

https://doi.org/10.1016/S0378-5173(97)00237-8Get rights and content

Abstract

The potency of surface coating liposomes with some materials was investigated for oral delivery of peptide drugs. In vitro release of insulin, a model peptide, from liposomes in the bile salts solution was markedly reduced by coating the surface with the sugar chain portion of mucin (Mucin-Lip) or polyethyleneglycol (PEG-Lip). Encapsulation of insulin into Mucin-Lip and PEG-Lip completely suppressed the degradation of insulin in the intestinal fluid, whereas uncoated liposomes suppressed it only partially. These results demonstrated that surface coating liposomes with PEG or mucin gained resistance against digestion by bile salts and increased the stability in the GI tract. When insulin was orally administered to rats as either a solution or non-charged liposome ((N)-Lip), no hypoglycemic effect was observed. Administration of insulin encapsulated in positively charged liposome ((+)-Lip) caused the rapid decrease in the plasma glucose level which recovered to the control level within 3 h. In contrast, PEG-Lip and Mucin-Lip caused a gradual decrease in the glucose level after administration. The hypoglycemic effect by PEG-Lip lasted for much longer duration than that of uncoated liposomes. The slow release of insulin from the surface coating liposomes achieved the longer duration of oral hypoglycemic activity. Consequently, the surface coating should be the potential way to add desirable functions to the liposome for oral drug delivery.

Introduction

Most peptides are ineffective by oral administration due to the low stability in the GI tract and their poor absorption. In order to improve their oral bioavailability, many strategies have been tested, such as a co-administration of absorption enhancers which increase the permeability of peptides through the intestinal membrane (Morishita et al., 1993, Hovgaard et al., 1995), a synthesis of their stable derivatives (Bruce and Susanna, 1995) and the development of special dosage forms by utilizing the micro or nano-particles as a drug carrier (Michel et al., 1991, Jenkins et al., 1994, Damge et al., 1995). Absorption enhancers showed several safety problems for clinical use. The bioactivity of peptides might be reduced through their required derivatization. On the contrary, a drug carrier system has many advantages. It is possible to control the release rate of peptides from particles after oral administration. Biodegradable materials can be used as components of particles for their safety in clinical use. Liposomes are one of the most potent candidates for such a drug carrier system. However, the efficacy of liposomes as an oral delivery system of peptide drugs has not yet been established. One of the reason for this problem is the instability of liposomes in GI tract. Liposomes were easily degraded by bile salts in GI tract because they interact with liposomes as surfactants. In order to use liposomes for oral dosage forms, a method to avoid this interaction was important.

In this study, we used insulin as a model peptide and investigated the possibility of surface coating liposomes as a tool for the oral delivery of peptide drugs.

Section snippets

Materials

Dipalmitoylphosphatidylcholine (DPPC), cholesterol (CHOL) and distearoylphosphatidylethanolamine-polyethyleneglycol 2000 (DSPE-PEG) were donated by Nippon Fine Chemical (Tokyo, Japan). Bovine insulin (25.7 IU/mg) and stearylamine (SA) were purchased from Sigma (St. Louis, MO). The other chemicals were of analytical grade.

Cetyl-mucin, one of the surface coating materials, was synthetized as follows: Mucin from pig stomach (Wako Pure Chemical, Osaka, Japan) was trypsinized for 5 h at 37°C,

Release of insulin from liposomes

The release profiles of insulin from liposomes are shown in Fig. 2. In the acidic solution (pH 2.0), four liposomes remained stable during the experimental period and no significant release of insulin was observed. Addition of bile salts into test solutions dramatically enhanced the release rate of insulin from the uncoated liposomes. Released amounts of insulin from uncoated liposomes reached ≈30% with sodium glycocholate and 20–50% with sodium taurocholate within 6 h. On the other hand, even

Discussion

It was reported that insulin entrapped by liposomes significantly reduced the plasma glucose levels of diabetic dogs by oral administration (Patel and Ryman, 1976), suggesting the possibility of liposomes as a tool of oral delivery of peptide drugs. However, the efficacy of liposomes as an oral dosage form has not been defined yet because of the complex behavior of liposomes in GI tract (Spangler, 1990, Fukunaga et al., 1991, Chodhari et al., 1994). As one of the main problems, liposomes were

Acknowledgements

We thank Dr Y. Namba (Nippon Fine Chemical) for the synthesis of DSPE-PEG and the gift of phospholipids. We also thank Ms K. Doi and Ms N. Saito (University of Shizuoka) for their technical assistance.

References (16)

There are more references available in the full text version of this article.

Cited by (0)

View full text